by Annie De Groot | Oct 8, 2018
EpiVax_Ancer_CICON_Application of Precision Cancer Immunotherapy Design Tools to Bladder Cancer_26Sep18
by Admin Epivax | Oct 22, 2016
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor. Adnexus MAbs. 2011 [ISPRI prediction of immunogenicity]
by Admin Epivax | Oct 22, 2016
Methods (Epitope Mapping Issue). Bill Kwok, editor, Methods 29 (2003) 289–298.
by Admin Epivax | Oct 22, 2016
Vaccine. 2015;33(10):1256-66 PMCID: PMC4331251